UG Healthcare Corporation

Deals, joint ventures & alliances

UG Healthcare to set up medical diagnostic centre in Nigeria through JV

The initial capital of the JV company, Health Focus Diagnostics Nigeria (PTY) Limited, is NGN10 million ($31,000).

Results

UG Healthcare Corp sees 68.9% y-o-y plunge in 3QFY2022 earnings of $10.7 mil

The group’s financial metrics declined y-o-y due to the lower ASPs of disposable gloves.

Results

UG Healthcare 1H22 net profit plunges 61.3% to $21.2 mil as glove prices fall

No dividend has been declared or recommended for 1HFY2022 as the group wishes to conserve cash for expansion and growth.
UG Healthcare reports 53.3% lower earnings of $10.6 mil for 1QFY2022 - THE EDGE SINGAPORE

Results

UG Healthcare reports 53.3% lower earnings of $10.6 mil for 1QFY2022

The group says it continues to experience “strong demand” for its ‘Unigloves’ brand at its downstream distribution operations.
Analysts mixed on UG Healthcare following halt in glove production due to EMCO - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on UG Healthcare following halt in glove production due to EMCO

RHB and CGS-CIMB have retained their respective 'neutral' and 'add' ratings for UG Healthcare.
UG Healthcare to conduct Covid-19 testing on employees as precautionary measure - THE EDGE SINGAPORE

Covid-19

UG Healthcare to conduct Covid-19 testing on employees as precautionary measure

"The Covid-19 testing will have minimal disruption to our manufacturing operations", says its executive and finance director.

Results

UG Healthcare's earnings surge over 70x to $22.7 mil for 1QFY2021 on higher revenue

Shares in UG Healthcare closed 2.5 cents higher or 2.6% up at 98 cents on Nov 5.

Company in the news

UG Healthcare receives listing and quotation notice from SGX; shareholders to vote for proposed share split on Sept 18

The company had, on August 31, proposed a one-to-three share split on a date to be determined by the board.

Company in the news

UG Healthcare raises $19.1 million in share placement

The gross proceeds of the placement will be used for the company’s capacity expansion plans as well as general working capital purposes.
×